2-(glucosylthio)ethyl groups as potential biolabile phosphate- protecting groups of mononucleotides

Helvetica Chimica Acta

Volumn 82, Issue 11, 1999, Pages 2044-2051

  Schlienger, Nathalie ^a   Périgaud, Christian ^a   Aubertin, Anne Marie ^b   Thumann, Christine ^b   Gosselin, Gilles ^a   Imbach, Jean Louis ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (GLUCOSYLTHIO)ETHYL DERIVATIVE; BETA GLUCOSIDASE; NUCLEOTIDE DERIVATIVE; PHOSPHATE; PRODRUG; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; ENZYME PURIFICATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SYNTHESIS;

EID: 0345476280     PISSN: 0018019X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2675(19991110)82:11<2044::AID-HLCA2044>3.0.CO;2-Y     Document Type: Article

References (38)

1. A. A. Arzumanov, N. B. Dyatkina, Russ. J. Bioorg. Chem. 1996, 22, 777.
2. C. Périgaud, J.-L. Girardet, G. Gosselin, J.-L. Imbach, 'Comments on Nucleotide Delivery Forms', in Antiviral Drug Design', Ed. E. De Clercq, JAI Press, London, 1996, pp. 147-172.
3. J. P. Krise, V. J. Stella, Adv. Drug Delivery Rev. 1996, 19, 287.
4. C. Périgaud, G. Gosselin, J.-L. Imbach, 'Minireview: from the Pronucleotide Concept to the SATE Phosphate Protecting Groups', in 'Current Topics in Medicinal Chemistry', Ed. J. C. Alexander, Blackwell Science Ltd., Oxford, 1997, p. 15.
5. C. Périgaud, G. Gosselin, J.-L. Imbach, Antiviral Ther. 1996, 1 (Suppl. 4), 39.
6. G. Gosselin, J.-L. Girardet, C. Périgaud, S. Benzaria, I. Lefebvre, N. Schlienger, A. Pompon. J.-L. Imbach, Acta Biochim. Pol. 1996, 43, 195.
7. C. Périgaud, J.-L. Girardet, I. Lefebvre, M.-Y. Xie, A.-M. Aubertin, A. Kirn, G. Gosselin, J.-L. Imbach, J.-P. Sommadossi, Antiviral Chem. Chemother. 1996, 7, 338.
8. E. Heymann, 'Carboxylesterases and Amidases', in 'Enzymatic Basis of Detoxification', Eds. W. B. Jacoby and R. R. Bend, Academic Press, New York, 1980, pp. 291-323.
9. T. Satoh, Rev. Biochem. Toxicol. 1987, 8, 155.
10. D. Egron, C. Périgaud, G. Gosselin, A.-M. Aubertin, J.-L. Imbach, Bull. Soc. Chim. Belg. 1997, 106, 461.
11. A. Esen, 'b-Glucosidases', in 'β-Glucosidases, Biochemistry and Molecular Biology', Ed. A. Esen, American Chemical Society, Washington DC, 1993, p. 1.
12. N. Sharon, H. Lis, Science (Washington, D.C.) 1989, 246, 227.
13. P. D. Stahl, J. Somsel Rodman, M. J. Miller, P. H. Schlesinger, Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 1399.
14. M. Monsigny, A.-C. Roche, P. Midoux, R. Mayer, Adv. Drug Delivery Rev. 1994, 14, 1.
15. J. N. Abbott, I. A. Romero, Mol. Medicine Today 1996, 2, 106.
16. I. Lefebvre, C. Périgaud, A. Pompon, A.-M. Aubertin, J.-L. Girardet, A. Kirn, G. Gosselin, J.-L. Imbach, J. Med. Chem. 1995, 38, 3941.
17. C. Thumann-Schweitzer, G. Gosselin, C. Périgaud, S. Benzaria, J.-L. Girardet, I. Lefebvre, J.-L. Imbach, A. Kirn, A.-M. Aubertin, Res. Virol. 1996, 147, 155.
18. E. R. Kern, 'Preclinical Evaluation of Antiviral Agents: in vitro and Animal Model Testing', in 'Antiviral Agents and Viral Diseases of Man', Eds. G. J. Galasso, R. J. Whitley, and T. C. Merigan, Raven Press, New York, 1990, pp. 87-123.
19. G. J. Veal, D. J. Back, Gen. Pharmacol. 1995, 26, 1469.
20. J. Balzarini, Pharm. World Sci. 1994, 16, 113.
21. A. Lavie, I. Schlichting, I. R. Vetter, M. Konrad, J. Reinstein, R. S. Goody, Nat. Med. (N.Y.) 1997, 3, 922.
22. A. Lavie, I. R. Vetter, M. Konrad, R. S. Goody, J. Reinstein, I. Schlichting, Nat. Struct. Biol. 1997, 4, 601.
23. L. W. Frick, D. J. Nelson, M. H. St Clair, P. A. Furman, T. A. Krenitsky, Biochem. Biophys. Res. Commun. 1988, 154, 124.
24. P. A. Furman, J. A. Fyfe, M. H. St Clair, K. Weinhold, J. L. Rideout, G. A. Freeman, S. Nusinoff Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya, D. W. Barry, Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 8333.
25. J. A. Harrington, W. H. Miller, T. Spector, Biochem. Pharmacol. 1987, 36, 3757.
26. R. P. Agarwal, A. M. Mian, Biochem. Pharmacol. 1991, 42, 905.
27. R. P. Agarwal, Int. J. Purine Pyrimidine Res. 1991, 2, 1.
28. A. Fridland. M. C. Connely, R. Ashmun, Mol. Pharmacol. 1990, 37, 665.
29. A. De Flora, E. Zocchi, L. Guida, C. Polvani, U. Benatti, Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 3145.
30. M. Magnani, M. Bianchi, L. Rossi, V. Stocchi, Biochem. Biophys. Res. Commun. 1989, 164, 446.
31. N. Schlienger, C. Périgaud, G. Gosselin, J.-L. Imbach, J. Org. Chem. 1997, 62, 7216.
32. L. B. Daniels, R. H. Glew, 'β-D-Glucosidases in Tissue', in 'Methods of Enzymatic Analysis. Enzymes 2: Esterases, Glycosidases, Lyases, Ligases', Ed. H. U. Bergmeyer, J. Bergmeyer, and M. Grassl, Verlag Chemie, Weinheim, 1974, p. 217.
33. M. P. Dale, H. E. Ensley, K. Kern, K. A. R. Sastry, L. D. Byers, Biochemistry 1985, 24, 3530.
34. N. Schlienger, C. Périgaud, G. Gosselin, I. Lefebvre, A. Pompon, A.-M. Aubertin, A. Kirn, J.-L. Imbach, Nucleosides Nucleotides 1997, 16, 1321.
35. L. A. Slotin, Synthesis 1977, 737.
36. F. Puech, G. Gosselin, I. Lefebvre, A. Pompon, A.-M. Aubertin, A. Kirn, J.-L. Imbach, Antiviral Res. 1993, 22, 155.
37. C. Moog, A. Wick, P. Le Ber, A. Kirn, A.-M. Aubertin, Antiviral Res. 1994, 24, 275.
38. 50, Synergism, Antagonism, Low-Dose Risk, Receptor Binding, and Enzyme Kinetics; Computer Software for Apple II Series and IBM-PC and Instruction Manual', Ed. Elsevier-Biosoft, Elsevier Science Publishers, Cambridge, U.K., 1985, p. 19.